Delivery Order SPE2DR25D1053-SPE2DR26FV467
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,086.96 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, competitively awarded through open competition. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $4,074.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections with an ultimate completion date of January 12, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order executed under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a $18,939.21 delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections, with a completion date of January 2, 2026. This is a firm fixed price, non-set-aside contract awarded on December 31, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36,484.03 to AmerisourceBergen Drug Corp for the supply of Zepbound 7.5 mg/0.5 mL pen injections, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $32,564.66 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injections on January 8, 2026, with an ultimate completion date of January 9, 2026. This firm fixed-price contract represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $12,172.95 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen injections. The award, issued on December 5, 2025, is a firm fixed-price delivery order with a completion date of December 8, 2025, and carries no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $22,874.67 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pen injections on January 7, 2026. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 8, 2026, with performance occurring at the awardee's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $15,753.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 15 mg/0.5 ml pen injections on December 2, 2025, with an ultimate completion date of December 3, 2025. This competitive award, which was not set-aside for any specific business category, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,214.64 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for the supply of Zepbound 12.5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $6,713.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 ml pen injections on January 9, 2026. This non-competitive delivery order, valued at approximately $6.7K, will be fulfilled from the contractor's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of January 12, 2026. The award represents a task order issued under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV467Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $48.4K to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pen injections on January 12, 2026, with completion scheduled for January 13, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a task order execution under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.9M global pharmaceutical support vehicle valued through December 2026 that enables the distributor to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, operating as a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical federal healthcare vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company serves essential medical procurement needs for military and veteran healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare institutions. This particular delivery order for Zepbound, a diabetes medication, exemplifies the company's broad portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain and reflects its capability to fulfill federal medical supply requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.4k | 1/11/26 |